| VIMSELTINIB 
| VIMSELTINIB | CASS ANTINEOPLASTIC KINASE INHIBITOR TREATMENT OF SYMPTOMATIC TENOSYNOVIAL GIANT CELL TUMOR (TGCT) | ORAL | Cmax 1.7 MICROMOLAR Tmax 1 HOUR VD 90 LITER PPB 96.5 PERCENT Cl 0.5 LITER / HOUR HT 144 HOUR SOLUBILITY VERY SLIGHTLY SOLUBLE IN WATER | COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R) PDB 7MFC (CRYSTAL STRUCTURE OF CSF1R IN COMPLEX WITH VIMSELTINIB) LIGAND CODE = Z6V (link to the list of PDB complexes) Download experimental 3D coordinates of Z6V with added hydrogens | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com VigiAccess SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |